SCYNEXIS, Inc.

SCYX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013
Assets
Cash & Equivalents $11.5M $35.7M $47.0M $32.2M $1.4M
Accounts Receivable — — — $1.1M $719.0K
Inventory — — — — —
Total Current Assets $45.0M $59.3M $48.4M $39.6M $3.0M
Property, Plant & Equipment $4.0K — $42.0K $0 $5.4M
Goodwill — — — — —
Intangible Assets (Excl. Goodwill) — — — — —
Total Assets $45.9M $59.8M $49.3M $39.7M $12.4M
Liabilities
Accounts Payable $3.8M $2.2M $619.0K $426.0K $1.9M
Total Current Liabilities $10.1M $3.7M $6.7M $5.3M $18.5M
Long-Term Debt $10.3M $14.3M $0 — —
Total Liabilities $24.4M $25.0M $7.3M $6.2M $33.3M
Stockholders' Equity
Retained Earnings $-205.3M $-180.1M $-150.1M $-117.5M $-113.3M
Total Stockholders' Equity $21.4M $34.8M $41.9M $33.4M $-108.1M
← Newer Page 2 of 2 Older →